International Congress on Default Mode Network

and other intrinsic networks in health and disease

Can Massallera, Sant Boi de Llobregat

Barcelona

4-5 June 2010

Dear colleagues:

We are pleased to announce a forthcoming conference:

Default Mode Network and other intrinsic networks in health and disease

The last decade has seen important advances in functional brain imaging. As part of these, since 2001 there has been growing interest in default mode network, a series of interconnected brain regions which are highly active at rest but de-activate during performance of many cognitive tasks. This network appears to have important functions related to self-directed thought and is being increasingly implicated in disorders such as dementia, schizophrenia and affective disorder.

This meeting will take place in Barcelona on the 4th and 5th of June. It will bring together leading researchers on the default mode network, and will provide a forum for sharing the latest information on the rapid evolving knowledge in the field. There will be keynote speeches from Marcus Raichle and Michael Greicius, and sessions will be devoted to recent advances in understanding of the default mode network, changes across the lifespan (including aging and age-related neurodegenerative disorders), and the default mode network in a range of psychiatric disorders. Connectivity and other brain networks will be also part of the programme.

This meeting will take place in Barcelona on the 4th and 5th of June. It will bring together leading researchers on the default mode network, and will provide a forum for sharing the latest information on the rapid evolving knowledge in the field. There will be keynote speeches from Marcus Raichle and Michael Greicius, and sessions will be devoted to recent advances in understanding of the default mode network, changes across the lifespan (including aging and age-related neurodegenerative disorders), and the default mode network in a range of psychiatric disorders. Connectivity and other brain networks will be also part of the programme. The conference takes place immediately before the Human Brain Mapping Conference in Barcelona and will be an official satellite of this meeting.

 

SINAPSE is a consortium of six Scottish universities; Aberdeen, Dundee, Edinburgh, Glasgow, St. Andrews, and Stirling. It has been established with funding from the Scottish Funding Council, the Chief Scientific Office and the six Universities.

The main research focus is on imaging the brain, with additional interests in oncology and cardiovascular imaging. The technology focus is primarily on magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), and electrophysiology (EEG). The network provides funding that has increased the number of key research staff and students within Scotland and it allows the sharing of skills and education via e-learning, seminars and other key events.
Aims & Objectives of SINAPSE

• To attract the best research leaders to a world-class network
• To build on existing strengths and foster exciting new neuroimaging research
• To promote research excellence and enhance Scotland's position as a global leader in imaging research
• To improve the research infrastructure and access to facilities
• To train the next generation of brain-imaging researchers
• To link the neuroimaging community together
• To generate opportunities for knowledge transfer
• To develop a sustainable long term environment for imaging research.

2010 World Molecular Imaging Congress

September 8-11, 2010 Kyoto, Japan at the International Conference Center

http://www.wmicmeeting.org/dev/

Plan to join us for WMIC 2010, which will be held September 8-11, 2010 in Kyoto, Japan. We will be meeting at the beautiful International Conference Center, which has been home to many conferences of global significance.

Like WMIC 2009, this year's program will be constructed primarily on the strength of submitted abstracts, and the Program Committee will be integrating many of these abstracts into special sessions that bring attendees from different disciplines together for a comprehensive examination of the role of molecular imaging in particular biomedical problems.

We are proud to announce our Keynote Speaker for the 2010 World Molecular Imaging Congress will be:


Shizuo Akira, M.D., Ph.D.

Shizuo Akira, M.D., Ph.D., (born January 27, 1953 in Higashiosaka) is a distinguished and highly cited professor at the Department of Host Defense, Osaka University, Japan. He has made ground-breaking discoveries in the field of immunology, especially in the area of innate host defense mechanisms.

Besides being one of the world’s most-cited scientists in 2006 and 2007, Dr. Akira was recognized as the scientist who had published the greatest number of “Hot Papers” over the preceding two years. He is the recipient of several international awards, including the Robert Koch Prize and the William B. Coley Award.

Among his greatest discoveries is the demonstration, through the ablation of toll-like receptor (TLR) genes, that TLRs recognize a discrete collection of molecules of microbial origin, and later the RNA helicases, RIG-I (retinoic-acid-inducible protein I) and MDA5 (melanoma differentiation-associated protein 5). All molecules belong to the pattern recognition receptors, which detect intruding pathogens and initiate anti-microbial responses in the host.


WMIC 2010 Steering Committee
June-Key Chung, MD, PhD, Secretary General of the Federation of Asian Societies for Molecular Imaging, Seoul National University Hospital, Korea
Johannes Czernin, MD, Immediate Past President of the Academy of Molecular Imaging, UCLA School of Medicine, Los Angeles, CA
Win-Ping Deng, Council Representative of the Federation of Asian Societies for Molecular Imaging, Taipei Medical University, Taiwan
Yasuhisa Fujibayashi, PhD, President of the Society for Molecular Imaging, University of Fukui, Japan
Andreas Jacobs, MD, President of the European Society for Molecular Imaging, Lab for Gene Therapy and Molecular Imaging, Germany
Clemens Lowik, PhD, Vice President of the European Society for Molecular Imaging, Leiden University Medical Center, Netherlands
Timothy McCarthy, PhD, President of the Academy of Molecular Imaging, Pfizer Global R&D, Groton, CT
Chrit Moonen, PhD, Immediate Past President of the Society for Molecular Imaging, Universite Victor Segalen Bordeaux, France

Program Committee Members

Program Committee Chair
Paula Foster, PhD, Robarts Research Institute, London, ON

Disease/Organ Processes Emphasis
Win-Ping Deng, PhD, Taipei Medical University, Taiwan
Zahi Fayad, PhD, Mount Sinai School of Medicine, New York, NY

In Vivo Studies Emphasis
June-Key Chung, MD, PhD, Seoul National University Hospital, Korea
Adriana Maggi, PhD, University of Milan, Italy

Methodology & Instrumentation Emphasis
Simon Cherry, PhD, University of California, Davis, CA
Vasilis Ntziachristos, PhD, Technical University of Munich, Germany

Molecular & Cellular Processes Emphasis
Ali Arbab, PhD, MD, Henry Ford Health System, Detroit, MI
Yasuyoshi Watanabe, PhD, MD, RIKEN, Kobe, Japan

Probes Emphasis
William Eckelman, PhD, Molecular Tracer, LLC, Bethesda, MD
Michal Neeman, PhD, Weizmann Institute of Science, Israel

Therapy Emphasis
Jeffery Evelhoch, PhD, Merck Research Laboratories, West Point, PA
Michael Tweedle, PhD, Ohio State University, Columbus, OH

Educational Workshop Organizers
Bernd Pichler, PhD, University of Tuebingen, Germany
Fabian Kiessling, PhD, Aachen University, Germany

2nd International Conference on Resting State Connectivity

Milwaukee, Wisconsin

September 17–19, 2010

http://www.restingstate.com/

Dear colleagues:

We are organizing the second International Conference on Resting State Connectivity in Milwaukee, Wisconsin, from September 17–19, 2010. This meeting aims to bring together key researchers working on the physiological background, application, and analysis of resting-state functional connectivity data in a very congenial and highly interactive setting. Thus, the number of attendees will be restricted in order to ensure priority to communication on a highly professional level instead of promotion or introduction of the phenomenon. During our three-day schedule, we will focus on the physical, physiological, statistical, and psychological implications of R‑fMRI and use this forum to define future directions in R-fMRI research.

We have assembled an impressive list of speakers (that continues to increase). We look forward to you joining us. More details, including registration information and abstract submission, can be found at: 

http://www.restingstate.com/

Invited speakers include:

Peter Bandettini, NIMH/NIH
Habib Benali, Université Pierre et Marie Curie
Rasmus Birn, University of Wisconsin–Madison
Bharat Biswal, UMDNJ–New Jersey Medical School
Melanie Boly, University of Liège
Michael Breakspear, Royal Brisbane Hospital
F. Xavier Castellanos, New York University
Gustavo Deco, Universitat Pompeu Fabra
Damien Fair, Oregon Health & Science University
Gary Glover, Stanford University
John Gore, Vanderbilt University Institute of Imaging Science
Michael Greicius, Stanford University
Christian Habeck, Columbia University
Michelle Hampson, Yale University School of Medicine
Silvina Horovitz, NINDS/NIH
Xiaoping Hu, Emory University
Anthony Hudetz, Medical College of Wisconsin
James Hyde, Medical College of Wisconsin
Fahmeed Hyder, Yale University
Viktor Jirsa, Theoretical Neuroscience Group (Paris, France)
Clare Kelly, New York University
Shella Kielholz, Emory University
Vesa Kiviniemi, Oulu University Hospital
Andreas Klienschmidt, INSERM (CEA/SAC/DSV/DRM/NeuroSpin)
Rolf Kötter, Radboud University Nijmegen Medical Centre
Stephen LaConte, Baylor College of Medicine
Helmut Laufs, Goethe-Universität Frankfurt am Main
David Leopold, NIH/NIMH
Shi-Jiang Li, Medical College of Wisconsin
Tom Liu, University of California, San Diego
Mark Lowe, Cleveland Clinic
Anthony McIntosh, The Rotman Research Institute Baycrest
Beth Meyerand, University of Wisconsin–Madison
Michael Milham, New York University Lagone Medical Center
Rosalyn Moran, Wellcome Trust Centre for Neuroimaging
Christopher Pawela, Medical College of Wisconsin
Scott Peltier, University of Michigan
Steve Petersen, Washington University School of Medicine
Serge Rombouts, Leiden University
Bart Rypma, The University of Texas at Dallas
Robert Shulman, Yale University
Amir Shmuel, McGill University
Olaf Sporns, Indiana University
Stephen Strother, University of Toronto
Robert Turner, Max Planck Institute
Chandan Vaidya, Georgetown University
Arno Villringer, Max Planck Institute
Martin Walter, Otto-von-Guericke-Universität Magdeburg
Susan Whitfield-Gabrieli, MIT
Christian Windischberger, University of Vienna
Yu-Feng Zang, Beijing Normal University

Thanks,
Bharat Biswal

The UCLA Advanced Neuroimaging Summer program - 2010

	Each year we are pleased to be able to offer a two week intensive summer program on advanced topics in neuroimaging. The purpose of this course is to provide a solid foundation in state-of-the-art functional neuroimaging methods. The course covers all aspects of MRI-based neuroimaging data acquisition, experimental design, and data analysis. In addition, students will interact closely with these lecturers in hands-on laboratory exercises and data analysis projects. Our 2010 Fourth Annual Summer Program will runfrom July 12 through July 23 and will be held on the UCLA campus. The course is presented as a mixture of classroom didactics and practical lab experience and is highly interactive. This year we are exploring the use of multiple modalities to answer neuroscientific questions. Our program is targeted to investigators with significant experience in neuroimaging who are eager to gain more tools and knowledge to apply to their work. This year we once again will have an extraordinary faculty of internationally known experts.
Thanks to the generosity of the National Institutes of Health under grant numbers T90 DA022768 and R90 DA023432 we are able to offer the course without tuition and are able to cover the costs of lodging for students form outside of the LA area. The program is open to applicants worldwide (though we are unable cover costs of travel). We are able to admit about 35 students each year. The course will feature hands-on laboratory sections in neuroanatomy and image analysis, demonstrations of EEG-fMRI and an opportunity to design experiments and collect data at the UCLA Center for Cognitive Neuroscience imaging laboratory. As in prior years, the lectures will be simulcast on the internet.
Preliminary Schedule for the Summer 2010 Session (subject to change) 7/12 7/13 7/14 7/15 7/20 8:30 Intro and Overview Cohen, Bookheimer Hemodynamics Buxton Psychophysics for fMRI Lenartowicz Statistical Modeling Mumford Advanced fMRI Modeling: % change, power Mumford 9:30 MRI acquisition I Cohen Relating neurophysiology and imaging signals Buxton Image registration –basic approaches Jenkinson Statistical inference Mumford Reporting fMRI data: Whole-brain and ROI analyses van Horn 10:30 Break 11:00 MRI acquisition II Cohen Expermimenal design I Bookheimer fMRI preprocessing Jenkinson fMRI data analysis - single subject Cohen fMRI Design Optimization and Quantitative Blood Flow Liu Noon Lunch 1:15 fMRI acquisition Lee Exp design II Bookheimer fMRI artifacts/quality control Cohen fMRI data group analysis Mumford Safety issues in neuroimaging Cohen 2:15 Intro to Cognitive Science Bookheimer Neurophysiology and Imaging signals Ringach Registration, fMRI processing exercises preprocessing lab Multiple comparisons Mumford More fMRI analysis exercises advanced FEAT lab 3:30 Anatomy exercise Breakout with groups- design stage Group breakouts - finalize study design Exercises-artifacts lab / basic FEAT lab Program tasks- MATLAB or Macstim Saturday and Sunday - Run Group-Designed Experiments at 3Tesla 7/19 7/20 7/21 7/22 7/23 8:30 Imaging Genetics and Multimodal Approaches Matthews Connectivity modeling, SEM Poldrack ERP/MEG/fMRI Simpson PET methods and ligands (tbn) tba 9:30 Bayesian statistics Lindquist Network analysis (tbn) Intermodality registration, theory (tbn) Imaging-genetics I: Techniques Glahn Q&A: Ask the Experts 10:30 Break 11:00 Nonparametric Statistics Lindquist Resting state fMRI (tbn) DTI and advanced physics Wedeen Imaging genetics II: Analyses Glahn Group Presentations Noon Lunch 1:15 Machine learning Poldrack EEG intro S. Jeste DTI analysis Wedeen tba Group Presentations 2:15 Functional connectivity Poldrack EEG-fMRI technology spectral analysis M. Cohen PET-MRI integration Thompson tba Closing Remarks, Reception 3:30 Group Project Analysis EEG-fMRI Demo High Resolution Tractography Lab Group Project Analyses Site Visit to Local Brewery Faculty Susan Bookheimer - UCLA Psychiatry Rick Buxton - UCSD Radiology Mark Cohen - UCLA Psychiatry David Glahn - Yale University Shafali Jeste - UCLA Psychiatry Jin-Hyung Lee - UCLA Electrical Engineering Agatha Lenartowicz - UCLA Psychiatry Martin Lindquist - Columbia University Thomas Liu - Dir, UCSD Ctr for Functional MRI Paul Matthews - VP, Imaging Genetics & Neurology, GSK Jeanette Mumford - UT Austin Russell Poldrack - Dir, Imaging Research Ctr, UT Austin Gregory Simpson - UCSF Jack van Horn - UCLA Van Wedeen - Harvard Radiology ...more to be announced

 

The UCLA Neuroimaging Training Program is funded by generous awards from the National Institutes of Health, grant numbers R90 DA022768 and T90 DA023422
 

Gordon Conference: In Vivo Magnetic Resonance July 25-30, 2010 Proctor Academy Andover, NH Chair: Risto A. Kauppinen Vice Chair: Greg J. Stanisz

Site Information A/V Information Poster Information Travel Information Bus Information Off-Site Housing Info Site Photos Conferee (Single) $825 Conferee (Double) $760 Conferee (Off-Site) $655 Guest (Single) $650 Guest (Double) $585 Guest (Off-Site) $480

---

Application Deadline

Applications for this meeting must be submitted by July 4, 2010. Please apply early, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed, it will be stated here. Applications will still be accepted for oversubscribed meetings. However, they will only be considered by the Conference Chair if more seats become available due to cancellations.

---

In Vivo applications of Magnetic Resonance (MR) continue to grow owing to technical advancements in several key domains of MR technology, including ultra-high magnetic field instrumentation, gradient and radio-frequency coils, image processing algorithms as well as contrast agents. All these advancements further promote MR as the most powerful single imaging modality to study living systems, spanning from anatomy and metabolic functions to detection and characterization of disease processes, and on spatial scales from individual cells to whole organs. The research field of in vivo MR is inherently interdisciplinary, bringing together scientists with backgrounds in physics, chemistry, engineering, biology and medicine. This conference focuses on the latest developments in both MR methodology and applications, providing a unique venue for exchanging ideas and developing collaborations. Young investigators and students are particularly encouraged to apply. In addition to the invited talks and poster presentations, the Hot Topics presentations - selected from the submitted abstracts - provide for inclusion of late-breaking developments. Topics to-be-covered include, but are not limited to: novel approaches for creating, detecting, and localizing the MR signal; applications of in vivo spectroscopy in disease and basic studies of metabolism; physical, chemical and biological mechanisms that affect the MR signal in vivo; development of new agents and approaches for manipulating the MR signal and contrast; functional MRI to study activation, blood flow and metabolism; and cellular function, from metabolism to gene expression to migration.

---

Contributors

---

SUNDAY
2:00 pm - 9:00 pm	Arrival and Check-in (Office Closed 6:00 pm - 7:00 pm)
6:00 pm	Dinner
7:30 pm - 7:40 pm	Introductory Comments by GRC Site Staff / Welcome by Chair, Risto Kauppinen
7:40 pm - 9:30 pm	FUTURE MR - LIGHTER AND FASTER
	Discussion Leader: Peter Luijten (Utrecht University Medical Centre, Utrecht, Holland)
7:40 pm - 8:20 pm	Klaas Pruessmann (ETH, Zurich, Switzerland) "Mind the field: the promise of dynamic magnetometry for in vivo MR"
8:20 pm - 8:35 pm	Discussion
8:35 pm - 9:15 pm	Mark Griswold (Case Western University, Cleveland, OH, USA) "Breaking the speed limits of MRI"
9:15 pm - 9:30 pm	Discussion
MONDAY
7:30 am - 8:30 am	Breakfast
8:30 am	Group Photo
9:00 am - 12:30 pm	ADVANCES IN MR HARDWARE AND SIGNAL ENCODING
	Discussion Leader: Tommy Vaughan (University of Minnesota, MN, USA)
9:00 am - 9:40 am	Lawrence Wald (Martinos Imaging Center, Boston, MA, USA) "Parallel transmit hardware, pulse design and SAR considerations for shaped excitations"
9:40 am - 10:00 am	Discussion
10:00 am	Coffee Break
10:30 am - 11:10 am	Andrew Kiriluta (Harvard University, Boston, MA, USA) "Traveling wave MR: From momentum in space to holography and beyond"
11:10 am - 11:30 am	Discussion
11:30 am - 12:10 pm	Maxim Zaitsev (University of Freiburg, Germany) "PatLoc: New approaches to spatial encoding in MRI"
12:10 pm - 12:30 pm	Discussion
12:30 pm	Lunch
1:30 pm - 4:00 pm	Free Time
4:00 pm - 6:00 pm	Poster Session I
6:00 pm	Dinner
7:30 pm - 9:30 pm	PUSHING THE LIMITS OF SPATIAL RESOLUTION
	Discussion Leader: Greg Stanisz (Sunnybrook Health Sciences Center, Toronto, Canada)
7:30 pm - 8:10 pm	Russel Jacobs (Caltech, Pasadena, CA, USA) "Microscopic MRI: compromises, qualifications and applications in small animal imaging"
8:10 pm - 8:30 pm	Discussion
8:30 pm - 9:10 pm	Christian Degen (MIT, Boston, MA, USA) "Nanoscale magnetic resonance imaging by force microscopy"
9:10 pm - 9:30 pm	Discussion
TUESDAY
7:30 am - 8:30 am	Breakfast
9:00 am - 12:30 pm	MRS: FROM MICE TO MAN
	Discussion Leader: Alena Horska (Johns Hopkins University, Baltimore, MD, USA)
9:00 am - 9:40 am	Jullie Pan (Yale University, New Haven, CT, USA) "Developments in ultra high field MR: evaluating the human brain in health and disease"
9:40 am - 10:00 am	Discussion
10:00 am	Coffee Break
10:30 am - 11:10 am	Gulin Oz (University of Minnesota, Minneapolis, MN, USA) "High field MR spectroscopy in spino-cerebellar ataxias: from mice to man"
11:10 am - 11:30 am	Discussion
11:30 am - 12:10 pm	Pratip Bhattacharya (Huntington Medical Research Institute, Pasadena, CA, USA) "Imaging tricarboxylic acid cycle metabolism in vivo by hyperpolarized 13C succinate"
12:10 pm - 12:30 pm	Discussion
12:30 pm	Lunch
1:30 pm - 4:00 pm	Free Time
4:00 pm - 6:00 pm	Poster Session II
6:00 pm	Dinner
7:30 pm - 9:30 pm	MAGNETIC PARTICLES AND NOVEL IMAGING APPLICATIONS
	Discussion Leader: Chrit Moonen (University of Bordeaux, France)
7:30 pm - 8:10 pm	Joern Borgert (Philips Healthcare, Hamburg, Germany) "Magnetic Particle Imaging"
8:10 pm - 8:30 pm	Discussion
8:30 pm - 9:10 pm	Alan Koretsky (NINDS, Bethesda, USA) "Micron scale particles for tracking new neurons in the rodent brain"
9:10 pm - 9:30 pm	Discussion
WEDNESDAY
7:30 am - 8:30 am	Breakfast
9:00 am - 12:30 pm	PRECLINICAL ADVANCEMENTS IN MR: NOVEL CONTRASTS AND BIOLOGICAL TARGETS
	Discussion Leader: Timothy Duong (University of Texas, San Antonia, TX, USA)
9:00 am - 9:40 am	Klaas Nicolay (Technical University of Eindhoven, Holland) "Visualising the invisible: Is molecular and cellular MRI there to stay?"
9:40 am - 10:00 am	Discussion
10:00 am	Coffee Break
10:30 am - 11:10 am	Olli Gröhn (University of Eastern Finland, Kuopio, Finland) "Applications of spin-lock MRI contrast in vivo"
11:10 am - 11:30 am	Discussion
11:30 am - 12:10 pm	Ricardo Carano (Genentech, Palo Alto, CA, USA) "MRI of tumor angiogenesis: from mice to man"
12:10 pm - 12:30 pm	Discussion
12:30 pm	Lunch
1:30 pm - 4:00 pm	Free Time
4:00 pm - 6:00 pm	Poster Session III
6:00 pm	Dinner
7:30 pm - 9:30 pm	HOT TOPICS SESSION
	Discussion Leader: Joel Garbow (Washington University, St Louis, MO, USA)
7:30 pm - 9:30 pm	Eight 10 minute (+5 minute discussion) presentations selected from submitted work
THURSDAY
7:30 am - 8:30 am	Breakfast
8:30 am - 9:00 am	Business Meeting
	(Nominations for the next Vice Chair; Fill out Conference Evaluation Forms; Discuss future Site & Scheduling preferences; Election of the next Vice Chair)
9:00 am - 12:30 pm	ADVANCING NEURO-MR TECHNIQUES
	Discussion Leader: Karla Miller (FMRIB, University of Oxford, UK)
9:00 am - 9:40 am	Xiang He (Washington University, St Louis, MO, USA) "Biophysical mechanisms of phase contrast in gradient echo MRI: theory and validation"
9:40 am - 10:00 am	Discussion
10:00 am	Coffee Break
10:30 am - 11:10 am	Penny Anne Gowland (University of Nottingham, UK) "Why MR signals from grey and white matter differ?"
11:10 am - 11:30 am	Discussion
11:30 am - 12:10 pm	Jeff Duyn (NINDS, Bethesda, MD, USA) "Origin and use of spontaneous BOLD fMRI fluctuations"
12:10 pm - 12:30 pm	Discussion
12:30 pm	Lunch
1:30 pm - 4:00 pm	Free Time
4:00 pm - 6:00 pm	Poster Session IV
6:00 pm	Dinner
7:30 pm - 9:30 pm	APPLIED MR METABOLOMICS
	Discussion Leader: Sabrina Ronen (UCSF, San Francisco, CA, USA)
7:30 pm - 8:10 pm	Joe Ackerman (Washington University, St Louis, MO, USA) "Plantae vs. Homo Sapiens: Secrets to survival revealed by 31P NMR"
8:10 pm - 8:30 pm	Discussion
8:30 pm - 9:10 pm	Xin Yu (Case Western University, Cleveland, OH, USA) "The metabolomics of normal and disease hearts"
9:10 pm - 9:30 pm	Discussion
FRIDAY
7:30 am - 8:30 am	Breakfast
9:00 am	Departure

---

The project described was supported by Award Number R13EB011782 from the National Institute Of Biomedical Imaging And Bioengineering. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Biomedical Imaging And Bioengineering or the National Institutes of Health.

About  |  Contact
	OVERVIEW SPEAKERS AGENDA
			Develop winning translational strategies to improve drug candidate survival What is your definition of Translational Medicine and how can we bring it to the next level? How is your individual Translational Medicine model affecting discovery and development efforts? Does your company embrace Translational Medicine inherently, adopt it with broad brush strokes because it is in vogue or ignore it altogether? I can guarantee that your answer will be completely different to everybody else who is reading this and therein lies the rub. Despite the diversity of opinion in this space, the overriding premise remains the same: How to translform from blockbuster to nichebuster and the potential of drug dependent biomarkers. What are the options for partnering to make things happen? What is required from the business and regulatory side to make this work? How to make biomarker driven treatment choices. The value and practical solutions for biomarkers in translational medicine. Find successful organizational collaborations for the development of drug dependent biomarkers. This meeting will not be a best practice conference with standard speaking slots and power point presentations. Yes, we have leading thinkers in this space on our speaker panel – but delegates in attendance will be as much a part of the meeting as these speakers. Discussion, debate and scrutiny will be the order of the meeting. This is your chance to be part of an Initiative to test theories, discuss successful models and collaborations and ultimately use the take-aways from these discussions to take your Discovery and Development process to the next level. Anybody with a real interest and passion for Translational Medicine will benefit from being involved so click here to be kept updated on developments.